Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acquired Blepharoptosis”

9 trials

Showing 9 of 9 results

Large-scale testing (Phase 3)Looking for participantsNCT06514612
What this trial is testing

LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of Acquired Blepharoptosis.

Who this might be right for
Acquired Blepharophimosis
Santen SAS 234
Large-scale testing (Phase 3)Looking for participantsNCT06683651
What this trial is testing

A Study in Chinese Patients With Acquired Blepharoptosis

Who this might be right for
Blepharoptosis
Santen Pharmaceutical Co., Ltd. 180
Post-approval studies (Phase 4)Not Yet RecruitingNCT07390578
What this trial is testing

Upneeq vs. Lumify Ptosis

Who this might be right for
Acquired Ptosis
Duke University 50
Testing effectiveness (Phase 2)Study completedNCT05715346
What this trial is testing

LEV102 Topical Gel in Acquired Blepharoptosis

Who this might be right for
Acquired Blepharoptosis
Levation Pharma, Ltd. 33
Large-scale testing (Phase 3)Study completedNCT03565887
What this trial is testing

Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis

Who this might be right for
Blepharoptosis
RVL Pharmaceuticals, Inc. 164
Large-scale testing (Phase 3)Study completedNCT03536949
What this trial is testing

Study of Safety of RVL-1201 in Treatment of Blepharoptosis

Who this might be right for
Blepharoptosis
RVL Pharmaceuticals, Inc. 234
Large-scale testing (Phase 3)Study completedNCT02436759
What this trial is testing

Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis

Who this might be right for
Acquired Blepharoptosis
RVL Pharmaceuticals, Inc. 140
Large-scale testing (Phase 3)Study completedNCT05945615
What this trial is testing

Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis

Who this might be right for
BlepharoptosisSynkinesisHyperkinesis+1 more
Milton S. Hershey Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT01848041
What this trial is testing

Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis

Who this might be right for
Blepharoptosis
RVL Pharmaceuticals, Inc. 46

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation